Bay Area Conference to Explore Themes Overlooked by ‘Mainstream Psychedelic Conversation’

October 23, 2024

Lykos, FDA Discuss Phase 3 MDMA Trial Plans

October 20, 2024

Study: Psilocybin Boosts Optimism

October 10, 2024

SEC Charges Phony Psilocybin Company

October 10, 2024

Steve Rio on Psychedelics, Safety and the Healing Power of ‘The Toad’

October 7, 2024

Experts Urge Further Study on Psychotherapy’s Influence on MDMA Therapy

October 4, 2024